Long non-coding RNA LINC00222 regulates GSK3β activity and promotes cell apoptosis in lung adenocarcinoma

Hongyan Zhang1, Yuan Wang2, Jibin Lu3

  • 1Department of Clinical Genetics, Shengjing Hospital of China Medical University, No.36 San Hao Street, Shenyang, 110004, PR China; Department of Thoracic surgery, Shengjing Hospital of China Medical University, No.36 San Hao Street, Shenyang, 110004, PR China.

Insights

Long noncoding RNA LINC00222 acts as a tumor suppressor in lung adenocarcinoma. Its downregulation promotes cancer cell proliferation and metastasis, suggesting it as a potential therapeutic target.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • Long noncoding RNAs (lncRNAs) are critical regulators of cellular processes.
  • Dysregulation of lncRNAs is implicated in various cancers, including lung adenocarcinoma.
  • Mechanisms of lncRNA action in lung adenocarcinoma are not fully understood.

Purpose of the Study:

  • To investigate the role of lncRNA LINC00222 in lung adenocarcinoma.
  • To explore LINC00222 as a potential biomarker and therapeutic target.

Main Methods:

  • Quantitative analysis of LINC00222 expression in 76 lung adenocarcinoma tissues and paired normal tissues.
  • In vitro experiments involving enforced expression of LINC00222 in lung adenocarcinoma cells.
  • Assessment of cell proliferation, migration, invasion, and apoptosis.
  • Analysis of glycogen synthase kinase-3β (GSK3β) activity and Wnt signaling pathway modulation.

Main Results:

  • LINC00222 was found to be significantly downregulated in lung adenocarcinoma tissues.
  • Enforced LINC00222 expression inhibited proliferation, migration, and invasion of lung adenocarcinoma cells.
  • Overexpression of LINC00222 induced apoptosis in cancer cells.
  • LINC00222 overexpression enhanced GSK3β activity, impacting the Wnt signaling pathway.

Conclusions:

  • LINC00222 functions as a tumor suppressor in lung adenocarcinoma.
  • LINC00222 holds potential as a prognostic biomarker for lung adenocarcinoma.
  • LINC00222 represents a promising therapeutic target for lung adenocarcinoma treatment.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.9K
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
26.5K
Eukaryotic RNA Polymerases00:58

Eukaryotic RNA Polymerases

RNA Polymerase (RNAP) is conserved in all animals, with bacterial, archaeal, and eukaryotic RNAPs sharing significant sequence, structural, and functional similarities. Among the three eukaryotic RNAPs, RNA Polymerase II is most similar to bacterial RNAP in terms of both structural organization and folding topologies of the enzyme subunits. However, these similarities are not reflected in their mechanism of action.
All three eukaryotic RNAPs require specific transcription factors, of which the...
27.1K
RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
11.0K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
15.2K